Panacea Biotech has bagged a 35 million dollar deal from UNICEF to supply Pentavalent vaccines. Rajesh Jain, Joint MD, Panacea Biotech said that presently, UNICEF (United Nations Children’s Fund) is the single largest consumer of Pentavalent vaccines produced by the company.
